Multiple myeloma. III. Effect of urethane therapy on plasma cell growth, abnormal serum protein components and Bence Jones proteinuria.
作者信息
RUNDLES R W, DILLON M L, DILLON E S
出版信息
J Clin Invest. 1950 Sep;29(9):1243-60. doi: 10.1172/JCI102362.
Abstract
摘要
相似文献
1
Multiple myeloma. III. Effect of urethane therapy on plasma cell growth, abnormal serum protein components and Bence Jones proteinuria.
J Clin Invest. 1950 Sep;29(9):1243-60. doi: 10.1172/JCI102362.
2
Relation of plasma cell growth to abnormal serum protein components and Bence Jones proteinuria in multiple myeloma.
J Clin Invest. 1950 Jun;29(6):842-3.
3
[Multiple myeloma; hyperproteinemia and Bence Jones proteinuria].
Arch Cuba Cancerol. 1951 Jul-Sep;10(7-9):258-69.
4
Carcinoma of the bronchus with Bence Jones proteinuria.
Br Med J. 1954 Nov 27;2(4899):1267-8. doi: 10.1136/bmj.2.4899.1267.
5
Proteins in multiple myeloma. VII. The free amino groups of Bence-Jones proteins.
J Biol Chem. 1957 Aug;227(2):1083-91.
6
[Excretion studies in Bence-Jones proteinuria].
Klin Wochenschr. 1957 Aug 1;35(15):773-5. doi: 10.1007/BF01542897.
7
[Multiple myeloma; hyperproteinemia and Bence Jones proteinuria].
Rev Med Cubana. 1951 Aug;62(8):593-603.
8
Fractionation of Bence-Jones protein by starch gel electrophoresis.
J Clin Pathol. 1958 Jul;11(4):334-8. doi: 10.1136/jcp.11.4.334.
9
Multiple myeloma with discordant M components in the serum and CSF.
Arch Intern Med. 1981 Sep;141(10):1374-6.
10
[Relations between a serum protein precipitable at 56 degrees C and Bence-Jones protein in a case of plasmocytoma].
Boll Soc Ital Biol Sper. 1961 Jul 15;37:631-2.
引用本文的文献
1
Multiple myeloma. IV. Abnormal serum components and Bence Jones protein.
J Clin Invest. 1951 Oct;30(10):1125-42. doi: 10.1172/JCI102533.
2
MELPHALAN THERAPY IN MYELOMATOSIS.
Br Med J. 1964 Apr 4;1(5387):859-65. doi: 10.1136/bmj.1.5387.859.
3
Multiple myeloma.
Calif Med. 1963 Aug;99(2):106-11.
4
Criteria for the identification of homogenous electrophoretic peaks in multiple myeloma.
Yale J Biol Med. 1962 Aug;35(1):84-95.
5
The formation of myeloma protein by a mouse plasma cell tumor.
J Exp Med. 1958 Jul 1;108(1):121-30. doi: 10.1084/jem.108.1.121.
6
[Present status of chemotherapy in human neoplastic diseases].
Klin Wochenschr. 1957 May 1;35(9):440-8. doi: 10.1007/BF01477945.
7
The carbohydrate of gamma-globulin and myeloma proteins.
J Exp Med. 1956 Aug 1;104(2):253-69. doi: 10.1084/jem.104.2.253.
8
The chemical control of cancer.
Public Health Rep (1896). 1954 Dec;69(12):1151-66.
9
Immunological relationships among the myeloma proteins.
J Exp Med. 1955 Jan 1;101(1):85-108. doi: 10.1084/jem.101.1.85.
本文引用的文献
1
2
Streptomycin-sensitive, -dependent, and -resistant Bacteria.
Science. 1948 Feb 6;107(2771):143-4. doi: 10.1126/science.107.2771.143.
3
A study of Bence-Jones protein, and of the metabolism in three cases of Bence-Jones proteinuria.
J Physiol. 1911 Mar 29;42(3):189-250. doi: 10.1113/jphysiol.1911.sp001432.
4
The Bence-Jones protein of multiple myelomatosis: its methionine content and its possible significance in relation to the aetiology of the disease.
Biochem J. 1949;44(5):610-8. doi: 10.1042/bj0440610.
5
An analysis of Bence-Jones protein.
Biochem J. 1941 Mar;35(3):433-45. doi: 10.1042/bj0350433.
6
The serum proteins in multiple myelomatosis.
Biochem J. 1940 Sep;34(8-9):1248-57. doi: 10.1042/bj0341248.
7
Immunological differences of crystalline Bence-Jones proteins.
Biochem J. 1940 Apr;34(4):487-9. doi: 10.1042/bj0340487.
8
ON THE PATHOGENESIS OF RENAL FAILURE ASSOCIATED WITH MULTIPLE MYELOMA. ELECTROPHORETIC AND CHEMICAL ANALYSIS OF PROTEIN IN URINE AND BLOOD SERUM.
J Clin Invest. 1944 Mar;23(2):163-6. doi: 10.1172/JCI101479.
9
A VISCOUS PROTEIN OBTAINED IN LARGE AMOUNT FROM THE SERUM OF A PATIENT WITH MULTIPLE MYELOMA.
J Clin Invest. 1943 Mar;22(2):137-42. doi: 10.1172/JCI101375.
10
BENCE-JONES PROTEINEMIA IN MULTIPLE MYELOMA.
J Clin Invest. 1943 Jan;22(1):67-75. doi: 10.1172/JCI101370.
Zotero 插件